For use with E0828 A needle tip and E0828 B gouge tip. Round knurled with threaded ended for tips. Most popular size or model.
Threaded ends permit guarding the needle and gouge within the handle. Set consists of one each : E0828 A needle tip, E0828 B gauge tip and E0828 C handle. Most popular size or model.
Battery operated single speed motorized handpiece, tip cover, supplied with 0.5 mm tungsten burr (E0815 0.5) and one battery size "AA".
5.5 mm disk shape burr. Diamond coated tip. Use with E0824 B handle.
Medicine Products:(Date:5/16/2008)...cal trials presented by Calpis Co., Ltd. at the Am...Annual Scientific Meeting and Exposition (ASH 2008...y supplement AmealPeptide reduces blood pressure i...D (Achieve Hypertension Efficacy with AmealPeptide...tive, Two-phase Randomized, Open-Label, Blinded En...
(Date:5/16/2008)... -- Superior launch strategies,allow best-in-class...,crowded markets. To secure "share of voice" for a...ptake strategies to support business needs and,ens...l companies achieve,attention in the market during...., "Best Practices for Winning Product Launch Suc...
(Date:5/16/2008)...d Information Technology That, Optimizes Cardiolo...ases Efficiency, SE...ced clinical and,information technology (IT) for t...www.siemens.com/healthcare ) will demonstrate the ...iology and cardiology workflow and image,processin...
(Date:5/16/2008)...PRNewswire-FirstCall/ -- BMP,Sunstone Corporation ...and,distribution pharmaceutical companies, today a...owing conferences:, (1) The Roth Annual China D...David Gao, Chief Executive Officer of the Company,... 2008, at 4:40 pm local time at the Regent Ho...
Breaking Medicine News(10 mins):Health News:Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials 2Health News:Global Pharmaceutical Launches: Best Practices for Winning Product Launch Successes 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 2Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 3Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 4Health News:Siemens Healthcare Showcases Its Portfolio of Image Management Solutions at SIIM 2008 5Health News:BMP Sunstone Announces Participation in May Investor Conferences 2... that a new extended-release formulation of metfor... diabetes as opposed// to the traditional twice a ...new drug, which is marketed under the brand name G...'s tolerance for higher doses of the drug, accordi...
...ted that patients who are at a high risk for devel...g a combination of vitamins E and C// plus ibuprof...in people who have a mutated gene for apolipoprote...on predisposing them to Alzheimer's disease. Re...
...ani Ramadoss made a reassuring announcement that w...HIV//. With the help of 48 additional centers to b...et of providing free anti-AIDS drugs to one lakh p...e a renewed thrust to India’s efforts in combating...
...rch conducted by the scientists at the University ...present in the air may have an adverse// effect on...found in the pollution from traffic exhaust, house..., cosmetics and clothes. Nanoparticles are atoms ...
Other Medicine News:(Date:5/15/2008)... FRANCISCO, May 15 /- Mediv...data from an ongoing Phase 1-2 clinical,trial of i...ll be presented,in an oral presentation at the 44t...ual Meeting in Chicago., Session title: New Tar... Session date and time: Monday, June 2 at 11:30 a...
(Date:5/15/2008)...BOURNE, Australia, May 15 /...the abstract for its upcoming oral,presentation on... Society,of Clinical Oncology (ASCO) will be acces...w.asco.org ) from 9pm on Thursday 15 May (US EDT)....tion of CYT997, a novel,cytotoxic and vascular dis...
(Date:5/15/2008)...DGEWATER, N.J., May 15 /- S...ced today that findings from the,landmark ATHENA s...herapy,for the treatment of patients with atrial f...of cardiovascular hospitalizations or death from a...0000002), meeting the study,primary endpoint. The ...
(Date:5/15/2008)...TON, May 15 /- CenterWatch, a publish...rket research about clinical,trials, finds that in...DC,(electronic data capture) systems. More than 75...dicated that they had been trained on three or mor...hat the effectiveness of,their EDC training had im...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Herley Announces Settlement Agreement with U S Government 18423 1Herley Announces Settlement Agreement with U S Government 18423 2Herley Announces Settlement Agreement with U S Government 18423 3HeartWare Receives Conditional Approval of IDE 18421 1HeartWare Receives Conditional Approval of IDE 18421 2HeartWare Receives Conditional Approval of IDE 18421 3Discovery of a novel mechanism for the development of colon cancer 18420 1Scientists identify gatekeepers of breast cancer transition to invasive disease 18418 1Scientists identify gatekeepers of breast cancer transition to invasive disease 18418 2... , LAINATE, Italy - July 4, 2007 - Cosmo Pharmaceu...liminary results from its,phase II/III study with ...rhoea. CB-01-11 is a broad spectrum, semi-syntheti...blet form. Through,the use of Cosmo,s MMX(tm) tech...the colon, bacteria in the gastro intestinal tract...
...uly 06, 2007 -- DOR BioPharma,Inc. (OTCBB: <a tar....com/Engine?Account=iwire&PageName=QUOTE&T...t.com/Engine?Account=iwire&PageName=QUOTE&...nced today that the European Patent,Office has gra...to,oral vaccination using mutated non-toxic forms ...
Other Medicine Technology:Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6